| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5500888 | Archives of Gerontology and Geriatrics | 2017 | 4 Pages |
Abstract
Despite being the highest consumers of medical interventions and medications, this review highlights that older patients remain under-represented in clinical trial with only modest improvements despite increasing awareness of the problem. Future research must continue to adapt to provide insight into the differential effects of medical treatments in older patients by ensuring that trial participants are representative of the patient population receiving the intended therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Miriam Thake, Andrew Lowry,